NeuriBo signs conditional license agreement with Dong-A NeuroBo Pharmaceutical Inc (NASDAQ: NRBO) shares dropped 27.8% on Friday after signing a conditional exclusive license deal with Dong-A ST Co. Ltd to develop and market DA-1726 and...
Read More
Akero announced positive data for its NASH treatment Akero Therapeutics Inc (NASDAQ: AKRO) gained 136.76% after announcing that its investigational lead drug had attained its primary endpoint of mid-stage study evaluation as a medication for a...
Read More
Immunocore reports positive data for its off-the-shelf ImmTAC medication Immunocore Holdings plc (NASDAQ: IMCR) dropped 22.09% after sharing data from the Phase 1 study of its off-the-shelf ImmTAC candidate targeting PRAME. Findings show a...
Read More
Shuttle Pharmaceutical closes its initial public offering Shuttle Pharmaceuticals Holding Inc (NASDAQ: SHPH) jumped 91.28% after the company finalized the closing of its IPO (initial public offering) of 1,225,888 common stock units with warrants...
Read More
Hollysys to go private in partnership with Beijing local government Hollysys Automation Technologies Ltd (NASDAQ: HOLI) jumped 16.51% following an announcement that a consortium led by the company’s management is planning to take the automation...
Read More
DoubleDown Interactive announces results of a special shareholder meeting DoubleDown Interactive Co Ltd (NASDAQ: DDI) jumped 12.2% after announcing that it held an extraordinary shareholder meeting on August 26, 2022, at 11:00 am in Seoul,...
Read More Everbridge is considering a potential sale to an unnamed buyer Everbridge Inc (NASDAQ: EVBG) jumped 17.39% following reports that the Burlington-based business is considering a possible deal with buyers comprising private equity and industrial...
Read More